(via TheNewswire)

Click Image To View Full Size

Vancouver, British Columbia, Canada – October 30, 2026 – TheNewswire - Frequency Exchange Corp. (“Frequency Exchange” or the “Company”) (TSXV: FREQ) (OTCQB: FRECF) (FSE: YC6): is pleased to announce the worldwide digital premiere of Superhuman 2: The Rebirth , the new four-part

docuseries from award-winning filmmaker Caroline Cory, featuring NIKKI Wellness Technology, the

series’ principal partner and the Company’s flagship frequency-based wellness platform and wearable

device.

Following its Official Selection debut at the DaVinci International Film Festival on September 26, 2026,

and red-carpet global premiere in Beverly Hills on October 4, 2026, Superhuman 2: The Rebirth begins

its worldwide digital release today, October 30, 2026. The four-part series examines emerging

perspectives on human potential, perception and cognitive performance, bringing together a team of

leading subject matter experts to provide research-driven insights on innovative approaches to

wellness.

The worldwide online premiere began today at 12:00 P.M. PST, with live conversations and Q&A sessions featuring participants in the production. Stephen Davis, CEO of Frequency Exchange and founder of NIKKI Technology, participated in a live conversation and Q&A, followed by the premiere of the four-part docuseries. Tickets for the online event are available at watch.superhuman2.com , with each ticket providing access to the complete series for seven days.

“Today’s worldwide digital premiere represents an important visibility milestone for NIKKI and Frequency Exchange,” said Stephen Davis. “NIKKI’s prominent integration throughout Superhuman 2: The Rebirth , together with my participation in the live premiere, introduces the technology and our story to an international audience as we continue advancing our broader commercialization and market awareness strategies.”

The global digital release builds on the Company’s previously announced participation in Superhuman 2: The Rebirth and provides international exposure for NIKKI as Frequency Exchange continues to advance commercialization across North America, the Middle East and other international markets. Additional information regarding the premiere and Superhuman 2: The Rebirth is available at watch.superhuman2.com and wearenikki.com/superhuman .

Further to Frequency Exchange’s ongoing initiatives to advance commercialization and global expansion, the Company has closed the second and final tranche (the “Final Tranche”) of its previously announced Non-Brokered Private Placement (the “Private Placement”), further to its news releases dated July 31, 2026, and September 11, 2026.

The Company issued an additional 241,131 units (the “Units”) at $0.25 per Unit for proceeds of $60,282.75, bringing the total Private Placement to 1,949,361 Units for aggregate proceeds of $487,340.25 when combined with the first tranche closing. Each Unit consists of one common share and one-half of one common share purchase warrant (the “Warrant”).

Each Warrant is exercisable at $0.40 for a period of 12 months from the date of issuance. Warrants are subject to an acceleration clause whereby, if the volume-weighted average trading price of the Common Shares on the TSX Venture Exchange is at least $0.70 per Common Share for 10 consecutive trading days, the Company may, at its sole option, accelerate the expiry date of the Warrants to a date not less than twenty-one (21) days following notice of the accelerated expiry date by way of news release.

The Company issued 8,000 non-transferable finder’s warrants (the “Finder’s Warrants”) and paid a cash commission of $2,000 to Research Capital Corp. The Finder’s Warrants are exercisable at $0.40 per share for a period of 12 months from the date of issuance and are subject to the same acceleration clause as the Warrants. All securities issued in connection with the Final Tranche are subject to a statutory hold period expiring March 1, 2027.

Net proceeds are expected to be used to expand sales and marketing, increase inventory, advance technology and platform development, grow the Company's team, support international expansion, and for general working capital.

The Private Placement is subject to TSX Venture Exchange final approval.

About Superhuman 2: The Rebirth

Superhuman 2: The Rebirth is a four-part investigative docuseries by award-winning filmmaker Caroline Cory that examines emerging scientific perspectives on human potential, perception, and cognitive performance. As outlined on superhuman2.com, the series uses structured experiments and interviews to explore phenomena that challenge conventional models of cognition and sensory processing, providing viewers with a research-driven look at evolving wellness approaches in the field.

NIKKI Wellness Technology is prominently integrated throughout the docuseries as an emerging wellness technology. Its integration offers audiences additional context on frequency-based wellness programs within real-world observational settings, aligning with the background provided at wearenikki.com/superhuman .

About Frequency Exchange Corp.

Frequency Exchange Corp. (TSXV: FREQ | OTCQB: FRECF | FSE: YC6) is a technology company building the next generation of wearable digital wellness solutions through its flagship platform, NIKKI. Unlike traditional wearable devices that primarily monitor health metrics, NIKKI delivers personalized frequency-based wellness programs designed to support sleep, stress, recovery, energy and overall wellbeing. Originally developed through research supporting individuals living with Lyme disease, NIKKI has evolved into a scalable wearable digital wellness platform addressing some of today’s largest global health challenges.

For additional information, visit www.frequencyexchangecorp.com or www.wearenikki.com

Investor Contacts

Frequency Exchange Corp.                                 Frequency Health Technologies Inc.

Stephen Davis                                         Nicole Sullivan

Chief Executive Officer                                 President

stephen@frequencyexchangecorp.com                 nicole.sullivan@wearenikki.com

604-684-2181                                                 604-684-2181

Forward‑Looking Information

This press release contains forward‑looking information and forward‑looking statements within the meaning of applicable Canadian securities legislation. Such statements include, but are not limited to, statements regarding the timing and scope of the Company’s commercialization activities, product launches, retail initiatives, international expansion, events, exposure through Superhuman 2: The Rebirth, completion of the Company’s financing, use of proceeds, inventory, distribution, and future growth.

Forward‑looking statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on forward‑looking statements. The Company undertakes no obligation to update such statements except as required by applicable securities laws.

Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company’s profile on SEDAR+ at www.sedarplus.ca .

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.